Pennsylvania: Local Alumnus Wins $5 Million Grant to Develop HIV Vaccine
December 21, 2012
Penn State Hazelton alumnus Dr. Gary R. Matyas has won the 2012 Avant-Garde Award for Medications Development, a $5 million award, from the National Institute on Drug Abuse. The award will fund his research to develop a vaccine against HIV that also prevents heroin addiction . Matyas works with the U.S. Military HIV Research Program at the Walter Reed Army Institute of Research in Silver Spring, Md., where research has already produced the anti-heroin component of the vaccine called haptens. The anti-heroin haptens is now ready for a more advanced, pre-clinical testing phase. Through the award, Matyas will receive $1 million per year for the next five years in support of this next phase of research and development. According to Matyas, "there is a strong correlation between heroin abuse and HIV infection, especially in developing countries." He goes on to note that work to create a combination heroin/HIV vaccine provides a unique opportunity to treat heroin abuse as well as to develop an effective preventive HIV vaccine.
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)